Innovator of Adipose Tissue and Stem Cell Platform Technologies

Provider of clinical grade, adipose tissue and adult stem cell collection, processing and cryo-preservation technology, providing first-in-class cellular therapy products and services for patients, physicians and researchers based on the transformative science of Regenerative and Personalized Medicine.


Who We Are

Founded in 2008, American CryoStem Corporation (CRYO) is a biotechnology pioneer, standardizing adipose tissue derived technologies for the fields of Regenerative and Personalized Medicine. CRYO is dedicated to supporting patients, and families in their pursuit of maintaining a healthy life and well-being today and in the future. The Company maintains a world class portfolio of intellectual property and patented technologies and operates a state-of-art, FDA-registered, clinical laboratory in Princeton, NJ dedicated to the collection, processing, bio-banking, culturing and differentiation of autologous adipose tissue (fat) and adipose derived stem cells (ADSCs) for use in Regenerative and Personalized Medicine. Leveraging its Standard Operating Procedures (SOPs), and laboratory platform the Company is creating a global footprint of licensed laboratory affiliates, physicians networks and patients utilizing our operating platform, products and services. The Company maintains licensed laboratory affiliates in Hong Kong, Tokyo, Japan and Shenzhen, China creating a fully operational international stem cell collection, processing and delivery platform. Our technologies allow shipment of any processed cellular sample stored in any of our laboratories to treatment facilities anywhere in the world where cellular therapy is approved.


cryo-logo


Our Cellular Platform Products

The company continues to expand its patented product portfolio with state-of-the-art Regenerative and Personalized Medicine offerings:

screenshot-2016-10-18-09-23-47


Our Processing & Bio-Banking Laboratory Facility

tanksAmerican CryoStem has pioneered the development and commercialization of a patented clinical processing and storage platform for individuals that prepares and cryo-preserves their adipose tissue and its cellular components including, Stromal Vascular Fraction (SVF) and Adipose Derived Stem Cells (ADSCs). This cellular platform allows each tissue sample we process suitable for use in cosmetic tissue grafting procedures, topical cosmetic products, or current/future stem cell therapies for use in Regenerative and Personalized Medicine.

Our world class clinical FDA registered laboratory provides the highest quality products and processing currently available in individuals in conformity with the FDA core regulations that control Human Cells, Tissues, and Cellular and Tissue-Based Products (HCT/Ps) (Title 21 CFR Part 1271 and 21 CFR 210,211).

Tissue & Stem Cell Facility Highlights

  • Clinical Adipose Tissue Processing & Bio-Banking Facility located in Princeton, New Jersey
  • FDA Registered FEI# 3008307548 , Licensed U.S. Tissue Bank
  • Multiple in-process quality management controls
  • ICCBBA Internationally Registered Facility #W3750 (International Blood and Tissue Banking Labeling Standards)
  • Complete end to end record keeping
  • Proprietary chain of custody methodologies
  • Validated Standard Operating Procedures (SOPs)
  • Patented medium line(s) 13

processwebOur adipose tissue processing storage and testing services operate in strict conformity with our internally developed, validated Standard Operating Procedures (SOPs) and Quality Management Program designed under the following FDA Guidance: “Current Good Tissue Practice (CGTP) and Additional Requirements for Manufacturers of Human Cells, Tissues and Cellular and Tissue-Based Products” December 2011

 

accreditation1


Our Cellular Platform Process

CRYO-Cycle-2014